Stem cell transplantation in Malaysia and future directions

Medical Journal of Malaysia

Volumn 63, Issue 4, 2008, Pages 279-280

  Fadilah, S Abdul Wahid ^a   Leong, C F ^a   Cheong, S K ^a,b  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; MYELOABLATIVE AGENT;

BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; EDITORIAL; GRAFT VERSUS HOST REACTION; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMPLANT REGISTRY; MALAYSIA; OVERALL SURVIVAL; PRACTICE GUIDELINE; RESEARCH ETHICS; TREATMENT FAILURE;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALAYSIA;

EID: 59849114321     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (14)

1. Thomas ED, Storb R, Clift RA, et al. Bone Marrow Transplantation. N Engl J Med 1975; 292: 895-902.
2. Gorin NC, Najman A and Duhamel G. Autologous bone-marrow transplantation in acute myeloid leukaemia. Lancet 1977; 1: 1050.
3. Gan GG, Zakaria Z, Sangkar JV, Haris AR, Bee PC, Chin E and Teh A. Adult Allogeneic Haematopoietic Stem Cell Transplantation: A Single Centre Experience in Malaysia. Med J Mal 2008; 63: 281-7.
4. Hooi LS and Lela Yasmin Mansor, editors. Third Report of the National Transplant Registry. Koala Lumpur: Clinical Research Centre, Ministry of Health of Malaysia; 2006.
5. To LB, Haylock DN, Kimber RJ and Juttner CA High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation. Br J Haematol 1984; 58: 399-410.
6. Deaver D. Peripheral blood progenitor cell or bone marrow transplantation. Curr Opin Oncol 2008; 20: 220-6.
7. Bacigalupo A. Mesenchymal stem cells and haemopoietic stem cell transplantation. Best Practice & Research Clin Haematol 2004; 17: 387-99.
8. Zuckerman T, Rowe M. Alternative donor transplantation in acute myeloid leukemia: which source and when? Curr Opin Hematol 2007; 14: 152-61.
9. Kato K, Khaled Y, Mineishi S. Reduced-intensity stem cell transplantation for hematological malignancies: current status and the future. Curr Stem Cell Res Ther 2007; 2: 149-62.
10. Brown JA, Boussiotis VA. Umbiliocal cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 2008; 127: 286-97.
11. Gluckman E, Broxmeyer HE, Auerbach AD et al. Haematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-8.
12. Mimeault M, Hauke R, Batra SK. Stem cells: A revolution in therapeutics - recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol & Therapeutics 2007; 82: 252-64.
13. Yamanaka S. Strategies and developments in the generation of patient-specific pluripotent stem cells. Stem Cell 2007; 1: 39-49.
14. Mimeault M, Batra SK. Recent advances on the significance of stem cells in tissue regeneration and cancer therapies Stem Cells 2006; 24: 2319-45.